Official RSS newsfeed from HD Drug Works (hddrugworks.org). http://hddrugworks.org Sat, 18 May 2013 16:58:30 +0100 FeedCreator 1.7.2 http://hddrugworks.org/images/M_images/rss20.gif http://hddrugworks.org Official RSS newsfeed from HD Drug Works (hddrugworks.org). http://hddrugworks.org/index.php?option=com_content&task=view&id=252&Itemid=26 Posted October 28 2009 by LaVonne Veatch Goodman Huntington's care provided by Huntington Study Group (HSG) professionals and Huntington's Disease Society of America (HDSA) is almost exclusively limited to specialty centers. This is exactly what our fund-raising and federal research dollars support: Expert medical care and social service support given by Centers of Excellence. This is all well and good, but . . What about families -- who probably represent the majority of Huntington's patients worldwide -- who don't have a center within geographic reach? What about those families whose medical care and support services are all too often poor to non-existent? Do our Huntington's organizations believe that responsibility for care ends at the center's door? Home - Opinions&Features Tue, 27 Oct 2009 11:22:22 +0100 http://hddrugworks.org/index.php?option=com_content&task=view&id=199&Itemid=119 Resveratrol is a natural substance found in small quantities in the skin of grapes, blueberries, cranberries and most highly concentrated in red wine. This substance which is available as a dietary supplement has been shown to protect several types of cells and organisms from oxidative stress, and to prolong life in some organisms. In this article, Dr. Goodman reviews the preliminary evidence that may support its use in Huntington's. Home - Research Thu, 02 Aug 2007 18:52:18 +0100 http://hddrugworks.org/index.php?option=com_content&task=view&id=196&Itemid=24 Per an announcement on July 26, MRSSI, Inc. announced today that Daniel P. van Kammen MD, PhD has joined as Chief Medical Officer. As such he will be responsible for the clinical development efforts of CHDI, Inc. CHDI was established in 2003 as a non-profit entity pursuing a biotech approach to finding therapies for Huntington disease (HD) . Read more... (http://www.chdi-inc.org/pdfs/van_Kammen_Announcement.pdf) Home - News Sun, 29 Jul 2007 15:57:55 +0100 http://hddrugworks.org/index.php?option=com_content&task=view&id=198&Itemid=24 Participating centers have been announced, and are recruiting. The Dimebon trials will need 90 participants and will last three months. Home - News Sun, 29 Jul 2007 16:37:20 +0100 http://hddrugworks.org/index.php?option=com_content&task=view&id=197&Itemid=24 The Huntington Study Group (HSG) is planning its first ever clinical research symposium. Though it is only for one half of a day, only research and clinical trial efforts that are directly relevant to people will be presented. No studies on mice or yeast allowed here. And more good news, the public is invited! Home - News Sun, 29 Jul 2007 16:15:44 +0100